SKB378/WIN378 (TSLP mAb): A Phase 1 clinical trial in healthy subjects has been completed in China, and its IND application for the treatment of COPD has also been approved by the NMPA. (PRNewswire) Aug 17, 2026
New trial • Chronic Obstructive Pulmonary Disease • Immunology
|